Randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of etanercept in patients with moderately active rheumatoid arthritis despite DMARD therapy
Crossref DOI link: https://doi.org/10.1186/s40064-015-0895-9
Published Online: 2015-03-05
Published Print: 2015-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Hobbs, Kathryn
Deodhar, Atul
Wang, Brian
Bitman, Bojena
Nussbaum, Joyce
Chung, James
Collier, David H
License valid from 2015-03-05
Article History
Received: 16 February 2015
Accepted: 17 February 2015
First Online: 5 March 2015